Showing results (51-60 of 109) with videos related to
Sort By:
Pageof 11
Cellular Oncology (Dordrecht, Netherlands)|April 13, 2021
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cellsJoana G Rodrigues, Henrique O Duarte, Catarina Gomes, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 13, 2017
A Specialist Macaque MHC Class I Molecule with HLA-B*27-like Peptide-Binding CharacteristicsNatasja G de Groot, Corrine M C Heijmans, Arnoud H de Ru, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology ApproachPleun Hombrink, Chopie Hassan, Michel G D Kester, et al.Plos One|May 8, 2012
Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cellsMarvin M van Luijn, Arjan A van de Loosdrecht, Margit H Lampen, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2020
Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional HierarchiesPeter van Balen, Michel G D Kester, Wendy de Klerk, et al.Science Advances|August 2, 2023
SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteomeDaniel Salas-Lloret, Nicolette S Jansen, Easa Nagamalleswari, et al.Journal of Proteomics|July 23, 2014
Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexesChopie Hassan, Michel G D Kester, Gideon Oudgenoeg, et al.Frontiers in Immunology|March 7, 2022
Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-ReactivityAicha Laghmouchi, Michel G D Kester, Conny Hoogstraten, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2016
Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DRMenno van Lummel, Peter A van Veelen, Arnoud H de Ru, et al.Nature Communications|May 20, 2024
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesisDaniel Salas-Lloret, Néstor García-Rodríguez, Emily Soto-Hidalgo, et al.Pageof 11